跳至主要内容
临床试验/CTRI/2022/09/045692
CTRI/2022/09/045692尚未招募3 期

A clinical study on the efficacy of homoeopathic medicines in the treatment of Primary Insomnia

Dr Prajakta Udmale1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年9月24日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
To study the efficacy of homoeopathic medicines in the treatment of primary insomnia

研究概览

简要总结

To study the efficacy of homoeopathic medicines in the treatment of primary insomnia.

Group 1: The indicated homoeopathic medicine will be administered with the stimulus control therapy and sleep restriction therapy.

Group 2: Placebo with the stimulus control therapy and sleep restriction therapy will be administered to this group.

Study Duration 1 month with follow up at every 15th and last on 30th day

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Patients of both the sex and between the age group of 20 years to 45 years and suffering from primary insomnia.

排除标准

  • Patients suffering from other systemic illnesses, hypothyroidism and hyperthyroidism and on any medication, Patients who have undergone any surgery within the past 6 months, Patient on the course of narcolepsy, or suffering from breathing-related sleep disorder, sleep apnea, circadian rhythm sleep disorder or parasomnia, Patient suffering from any another mental disorder such as major depressive disorder, generalized anxiety disorder, a delirium, neurological disorders, Patient suffering from insomnia due to the direct physiological effects of a substance, on alcoholism, tobacco addiction.

结局指标

主要结局

To study the efficacy of homoeopathic medicines in the treatment of primary insomnia

时间窗: 1 month

次要结局

  • To clinically evaluate the efficacy of homoeopathic medicines in the treatment of primary insomnia(1 month)

研究者

发起方
Dr Prajakta Udmale
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验